AG Mednet launches Judi to help sponsors, CROs manage clinical events

By Melissa Fassbender contact

- Last updated on GMT

AG Mednet is an electronic data collection and submission service provider. (Image: iStock/MickeyCZ)
AG Mednet is an electronic data collection and submission service provider. (Image: iStock/MickeyCZ)

Related tags: Contract research organization

AG Mednet's SaaS solution, Judi, helps sponsors and contract research organizations (CROs) manage clinical events from trigger to final adjudication.

According to Abraham Gutman, President and CEO at AG Mednet, the new tool represents a departure from the way e-Adjudication is performed, as it was developed specifically for adjudication.

It’s not an EDC system used for that process, nor a general forms management system,​” he explained. “Judi differs fundamentally from other solutions in that it is a computer implementation of the adjudication language​.”

As Gutman further explained, Judi implements the language of adjudication, creating a direct and visible relationship between the trial charter, which describes all the processes, documents, reports and outcomes, and the system’s configuration.

Since everyone processes event types differently, CROs and sponsors do not have to adjust their preferred methodologies to the system​,” he said. “Rather, the system can be used to describe their processes and it translates it into the necessary computer code to manage the project​.”

Judi provides several benefits, specifically in areas such as data quality and query reduction, according to Gutman. Additionally, a graphical user interface displays information and enables users in various roles to view the clinical trial’s state from their different perspectives.

Sponsors and CROs using Judi also benefit from significant economies of scale in the addition of novel features into the system​,” Gutman added.

Related news

Show more

Related products

show more

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-May-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us


View more